| Company Name: | Simulations Plus, Incorporated | | Ticker Symbol: | SLP | | | WWW Address: | www.simulations-plus.com | | CEO: | Walter S. Woltosz | | No. of Employees: | 32 | | Common Issue Type: | CS | | Business Description: | The Company designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students.
|
| | | Industry Information: | COMPUTER SOFWARE & SERVICES - Business Software & Services [more like this] | |
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 1.32 | -0.14 | 0.42 | 2.37 | 1.44 | 1.44 | 1.30 | 12676 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 21.0 | 15.9 | 1.42 | 0.11 | 0.00 | 14.7 | 0.0 | 2.05 - 0.79 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 1.32 | $ | | PE Ratio - LTM | 14.7 | |
| Market Capitalisation | 20.9 | mil |
| Latest Shares Outstanding | 15.9 | mil |
| Earnings pS (EPS) | 0.11 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 280,249 | $ |
| Effective Tax Rate | 29.5 | % |
| Float | 8.5 | mil |
| Float as % of Shares Outstanding | 53.8 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 42.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 14.10 | % |
| Gross Profit Margin | 82.6 | % |
| EBITDA Margin | 25.6 | % |
| Pre-Tax Profit Margin | 22.5 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | 11.1 | % |
| Return on Equity (ROE) | 12.9 | % |
| Return on Capital Invested (ROCI) | 12.9 | % |
| Current Ratio | 10.3 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 0.61 | $ |
| Cash pS | 0.47 | $ |
| Book-Value pS | 0.69 | $ |
| Tangible Book-Value pS | 0.57 | $ |
| Cash Flow pS | 0.12 | $ |
| Free Cash Flow pS | 0.11 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.91 | |
| Price/Tangible Book Ratio | 2.32 | |
| Price/Cash Flow | 10.6 | |
| Price/Free Cash Flow | 12.0 | |
| P/E as % of Industry Group | 50.0 | % |
| P/E as % of Sector Segment | 33.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
| 
|  | | Share price performance intraday |
| 
| |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -13.2 | 86 | 84 | 188 |
| 4 Weeks | 1.63 | 1.30 | 1.45 | -9.0 | 85 | 103 | 1,757 |
| 13 Weeks | 1.82 | 1.30 | 1.81 | -27.1 | 68 | 144 | 8,795 |
| 26 Weeks | 2.05 | 1.09 | 1.11 | 18.9 | 99 | 237 | 29,568 |
| 52 Weeks | 2.05 | 0.79 | 1.01 | 30.7 | 106 | 218 | 54,302 |
| YTD | 2.05 | 0.79 | - | 43.5 | 117 | 214 | 48,561 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 1.48 | 1.46 | 1.53 | 1.51 | 1.37 | 1.42 | 1.52 |
|
| |
| GROWTH RATES | 5-Year Growh | R² of 5-Year Growth | 3-Year Growth |
| Revenue | 14.44 | 77.0 | 16.03 |
| Income | 19.36 | 23.6 | 37.03 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 91.24 | NA | 92.40 |
| R&D | 21.56 | NA | 35.53 |
| Normalized Inc. | 17.92 | NA | 31.12 |
| | | CHANGES | YTD vs. Last YTD | Curr Qtr vs. Qtr 1-Yr ago | Annual vs. Last Annual |
| Revenue % | 2.4 | -8.6 | 1.2 |
| Earnings % | -6.0 | -24.4 | 17.7 |
| EPS % | -22.2 | -25.0 | 37.5 |
| EPS $ | -0.02 | -0.01 | 0.03 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 68.85 |
| Current Ratio | 9.9 |
| Quick Ratio (Acid Test) | 8.9 |
| Liquidity Ratio (Cash) | 6.57 |
| Receivables Turnover | 4.3 |
| Average Collection Period | 84 |
| Working Capital/Equity | 80.2 |
| Working Capital pS | 0.49 |
| Cash-Flow pS | 0.14 |
| Free Cash-Flow pS | 0.10 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 10.20 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 14.2 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 7.5 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 35974.2 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.93 |
| Tobin's Q Ratio | 1.81 |
| Current P/E Ratio - LTM | 14.70 |
| Enterprise Value (EV)/EBITDA | 6.13 |
| Enterprise Value (EV)/Free Cash Flow | 14.40 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.32 |
| Price/Book Ratio - LTM | 1.91 |
| Price/Cash Flow Ratio | 10.6 |
| Price/Free Cash Flow Ratio - LTM | 12.0 |
| Price/Sales Ratio | 2.29 |
| P/E Ratio (1 month ago) - LTM | 17.4 |
| P/E Ratio (26 weeks ago) - LTM | 10.1 |
| P/E Ratio (52 weeks ago) - LTM | 12.6 |
| 5-Y High P/E Ratio | 103.0 |
| 5-Y Low P/E Ratio | 12.0 |
| 5-Y Average P/E Ratio | 37.3 |
| Current P/E Ratio as % of 5-Y Average P/E | 39 |
| P/E as % of Industry Group | 50.0 |
| P/E as % of Sector Segment | 33.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.7 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.05 |
| Tangible Book Value pS - LTM | 0.57 |
| Book Value pS - LTM | 0.69 |
| Capital Invested pS | 0.63 |
| Cash pS - LTM | 0.47 |
| Cash Flow pS - LTM | 0.12 |
| Free Cash Flow pS - LTM | 0.11 |
| Earnings pS (EPS) | 0.11 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 18.59 |
| Free Cash Flow Margin 5YEAR AVG | 16.03 |
| Net Profit Margin | 19.2 |
| Net Profit Margin - 5YEAR AVRG. | 14.8 |
| Equity Productivity | 0.90 |
| Return on Equity (ROE) | 17.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 15.3 |
| Capital Invested Productivity | 0.90 |
| Return on Capital Invested (ROCI) | 17.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 15.3 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 14.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | 13.2 |
| Gross Profit Margin | 82.6 |
| Gross Profit Margin - 5YEAR AVRG. | 79.2 |
| EBITDA Margin - LTM | 25.6 |
| EBIT Margin - LTM | 22.5 |
| Pre-Tax Profit Margin | 27.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 20.8 |
| Effective Tax Rate | 29.5 |
| Effective Tax Rate - 5YEAR AVRG. | 20.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 151 |
| Revenue per Employee | 280,249 |
| Net Income per Employee | 53,924 |
| Average Collection Period | 85 |
| Receivables Turnover | 4.3 |
| Day's Inventory Turnover Ratio | 66 |
| Inventory Turnover | 5.4 |
| Inventory/Sales | 3.8 |
| Accounts Payble/Sales | 2.02 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 1.13 |
| Fixed Assets Turnover | 3.32 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 1.52 |
| Revenue per $ Plant | 87.38 |
| Revenue per $ Common Equity | 0.90 |
| Revenue per $ Capital Invested | 0.90 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 41.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 44.8 |
| Research & Devlopment (R&D) as % of Revenue | 11.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 11.0 |
|
|  





|
| |
 |  |